Clinical trials referenced in this document:
Documents that mention this clinical trial
A Randomized Pharmacokinetic Study in Healthy Male Subjects Comparing a High-concentration, Citrate-free SB5 Formulation (40 mg/0.4 ml) and Prior SB5 (Adalimumab Biosimilar)
https://doi.org/10.1007/s40744-022-00471-8
Funding for this research was provided by:
Samsung Bioepis
Article History
Received: 15 April 2022
Accepted: 8 June 2022
First Online: 1 July 2022